Join
Live feed
·
PRReleasevia Quantisnow
Class Acceleration Corp. logo

Claritas Announces Option to Acquire Rights to Novel Drug for Treatment of COVID-19 Related ARDS

ByQuantisnow·Wall Street's wire, on your screen.
CLAS· Class Acceleration Corp.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLAS (Class Acceleration Corp.) and more on Quantisnow.